Skip to Main Content

Paper Details

Correcting the drug development paradigm for glioblastoma requires serial tissue sampling.
Nat Med
7
2023
glioblastoma
Author NameAffiliation
John F de GrootUniversity of California San Francisco (UCSF)
Patrick Y WenCenter for Neuro-Oncology, Dana Farber Cancer Institute and Harvard Medical School
Howard ColmanHuntsman Cancer Institute, University of Utah
Howard ColmanHuntsman Cancer Institute, University of Utah
Timothy F CloughesyUniversity of California Los Angeles (university of california los angeles)
Timothy F CloughesyUniversity of California Los Angeles (university of california los angeles)
Minesh P MehtaMiami Cancer Institute
Isabel Arrillaga-RomanyMassachusetts General Hospital
Priya KumthekarFeinberg School of Medicine, Northwestern University
Roel G W VerhaakYale University
Roel G W VerhaakYale University
Tracy T BatchelorBrigham and Women's Hospital
Tracy T BatchelorBrigham and Women's Hospital
Michael WellerUniversity Hospital Zurich, University of Zurich
Michael A VogelbaumH. Lee Moffit Cancer Center and Research Institute
Matthias PreusserMedical University of Vienna
Matthias PreusserMedical University of Vienna
Mitchel S Berger
Mitchel S Berger
  • 1 - 19

Datasets

Release 1.2